A. G. Nugent

426 total citations
24 papers, 335 citations indexed

About

A. G. Nugent is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, A. G. Nugent has authored 24 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in A. G. Nugent's work include Nitric Oxide and Endothelin Effects (6 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers) and HER2/EGFR in Cancer Research (3 papers). A. G. Nugent is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers) and HER2/EGFR in Cancer Research (3 papers). A. G. Nugent collaborates with scholars based in United Kingdom, Ireland and United States. A. G. Nugent's co-authors include C. McGurk, Ken K. Y. Ho, GD Johnston, Daniel F. McAuley, A. Margot Umpleby, David Hoffman, Suzanne Maguire, Mark W. Duncan, Troels Wolthers and DP Nicholls and has published in prestigious journals such as Clinical Chemistry, American Journal of Physiology-Endocrinology and Metabolism and Heart.

In The Last Decade

A. G. Nugent

22 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. G. Nugent United Kingdom 12 150 100 73 50 47 24 335
Laurent Larifla Guadeloupe 14 84 0.6× 77 0.8× 95 1.3× 36 0.7× 61 1.3× 32 408
Jichao Sun China 11 148 1.0× 83 0.8× 46 0.6× 56 1.1× 21 0.4× 22 403
Li Jin Pu China 10 141 0.9× 120 1.2× 46 0.6× 77 1.5× 23 0.5× 12 389
Keiko Aikawa Japan 9 110 0.7× 54 0.5× 84 1.2× 36 0.7× 28 0.6× 18 416
Elisabet Nerpin Sweden 10 67 0.4× 70 0.7× 69 0.9× 70 1.4× 21 0.4× 16 393
Anthony M. Robinson United Kingdom 8 292 1.9× 50 0.5× 60 0.8× 94 1.9× 26 0.6× 12 506
Claudia Campusano Chile 11 104 0.7× 39 0.4× 36 0.5× 83 1.7× 30 0.6× 41 323
Kiriko Wada Japan 11 138 0.9× 54 0.5× 59 0.8× 146 2.9× 95 2.0× 21 413
Yesmino Elia Canada 12 113 0.8× 79 0.8× 20 0.3× 56 1.1× 62 1.3× 25 360
J.L. Taft Australia 7 158 1.1× 63 0.6× 39 0.5× 36 0.7× 31 0.7× 13 343

Countries citing papers authored by A. G. Nugent

Since Specialization
Citations

This map shows the geographic impact of A. G. Nugent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. G. Nugent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. G. Nugent more than expected).

Fields of papers citing papers by A. G. Nugent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. G. Nugent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. G. Nugent. The network helps show where A. G. Nugent may publish in the future.

Co-authorship network of co-authors of A. G. Nugent

This figure shows the co-authorship network connecting the top 25 collaborators of A. G. Nugent. A scholar is included among the top collaborators of A. G. Nugent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. G. Nugent. A. G. Nugent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kauffman, John F., José M. Cuevas, John Feiner, et al.. (2025). Discovery of ultra short β-peptoids with selective activity against drug-resistant Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 290. 117531–117531. 1 indexed citations
3.
Shetye, Gauri, Mallique Qader, A. G. Nugent, et al.. (2024). Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club. ACS Omega. 9(44). 44749–44759.
4.
Nugent, A. G., et al.. (2021). Pituitary metastasis: a clinical overview.. PubMed. 90(3). 146–150. 11 indexed citations
5.
Lockhart, Samuel N., Ian Wallace, A. G. Nugent, et al.. (2019). A Survey of Patient's Perceptions and Proposed Provision of a 'Patient Portal' in Endocrine Outpatients.. PubMed. 88(3). 157–161. 2 indexed citations
6.
Nugent, A. G. & Charles E. Moore. (2010). Adolescent Awareness of Risk Factors Associated with Head and Neck Cancer vs Lung Cancer. The Laryngoscope. 120(S4). S170–S170. 3 indexed citations
7.
Nugent, A. G., Kin‐Chuen Leung, David Sullivan, Anne T. Reutens, & Ken K. Y. Ho. (2003). Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Clinical Endocrinology. 59(6). 690–698. 32 indexed citations
8.
Maguire, Suzanne, Daniel F. McAuley, C. McGurk, et al.. (2001). Bradykinin Infusion in Chronic Cardiac Failure and the Effects of Captopril. European Journal of Heart Failure. 3(6). 671–677. 3 indexed citations
9.
Wolthers, Troels, David Hoffman, A. G. Nugent, et al.. (2001). Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. American Journal of Physiology-Endocrinology and Metabolism. 281(6). E1191–E1196. 96 indexed citations
10.
McAuley, Daniel F., C. McGurk, A. G. Nugent, et al.. (2000). Vasoconstriction to Endothelin-1 is Blunted in Non-Insulin-Dependent Diabetes: A Dose-Response Study. Journal of Cardiovascular Pharmacology. 36(2). 203–208. 19 indexed citations
11.
McAuley, Daniel F., A. G. Nugent, C. McGurk, et al.. (2000). Vasoconstriction to endogenous endothelin-1 is impaired in patients with Type II diabetes mellitus. Clinical Science. 99(3). 175–179. 13 indexed citations
12.
McAuley, Daniel F., Daniel F. McAuley, Colm G. Hanratty, et al.. (1999). Effect of Methionine Supplementation on Endothelial Function, Plasma Homocysteine, and Lipid Peroxidation. Journal of Toxicology Clinical Toxicology. 37(4). 435–440. 11 indexed citations
13.
Maguire, Suzanne, A. G. Nugent, C. McGurk, GD Johnston, & DP Nicholls. (1998). Abnormal vascular responses in human chronic cardiac failure are both endothelium dependent and endothelium independent. Heart. 80(2). 141–145. 47 indexed citations
14.
McGurk, C., A. G. Nugent, Daniel F. McAuley, & Bernard Silke. (1997). Sources of inaccuracy in the use of the Hawksley random-zero sphygmomanometer. Journal of Hypertension. 15(12). 1379–1384. 11 indexed citations
15.
McAuley, Daniel F., C. McGurk, A. G. Nugent, et al.. (1997). Forearm endothelium‐dependent vascular responses and the potassium‐ATP channel. British Journal of Clinical Pharmacology. 44(3). 292–294. 2 indexed citations
16.
Nugent, A. G., C. McGurk, & GD Johnston. (1996). Forearm vascular responses to serotonin are not mediated by products of cyclooxygenase. British Journal of Clinical Pharmacology. 41(3). 241–243. 1 indexed citations
17.
Nugent, A. G., et al.. (1994). Assay of the c-erbB-2 Oncogene Encoded Protein by ELISA and Immunocytochemistry in Human Breast Cancer. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 31(2). 171–173. 4 indexed citations
18.
Nugent, A. G., et al.. (1992). Enzyme-Linked Immunosorbent Assay of C-Erbb-2 Oncoprotein in Breast Cancer. Clinical Chemistry. 38(8). 1471–1474. 21 indexed citations
19.
Nugent, A. G., E. McDermott, N. J. O’Higgins, J. J. Fennelly, & Michael J. Duffy. (1992). Measurement of erbB-2 oncoprotein in human breast cancers by ELISA. Biochemical Society Transactions. 20(1). 82S–82S. 2 indexed citations
20.
Nugent, A. G.. (1983). Fit for work: the introduction of physical examinations in industry.. PubMed. 57(4). 578–95. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026